Wegovy Side Effects: What Should You Know?

Wegovy side effects are an important consideration for Australians using semaglutide for weight management. Wegovy contains semaglutide, a medicine that is available in Australia as a prescription treatment.

However, like other medicines, Wegovy can cause unwanted effects. In particular, gastrointestinal side effects are among the most frequently reported reactions. Therefore, understanding what may occur can help you recognise expected symptoms and identify signs that require medical attention.

Wegovy Common Side Effects

The most frequently reported Wegovy common side effects involve the digestive system. These include nausea, diarrhoea, constipation, vomiting and abdominal pain.

For example, Australian product information reports nausea in 38.3% of adults treated with Wegovy in the cited phase 3 trials. Diarrhoea occurred in 26.8%, while constipation and vomiting each occurred in 21.8%.

Additionally, some people experience headache, dizziness, indigestion, abdominal bloating, flatulence or reflux. However, side effects can vary between individuals.

Semaglutide Side Effects and Digestion

Semaglutide side effects can become noticeable as treatment progresses or when the dose changes. Consequently, people should follow their prescriber’s dosing instructions rather than changing the dose themselves.

Moreover, nausea and vomiting can contribute to dehydration. Therefore, maintaining adequate fluid intake is important, particularly when vomiting or diarrhoea occurs. The Australian Consumer Medicine Information specifically highlights dehydration as a concern associated with these gastrointestinal reactions.

Wegovy Adverse Effects During Treatment

Wegovy adverse effects do not affect everyone in the same way. Some people may experience mild digestive symptoms, while others may have more troublesome reactions.

Furthermore, dizziness can occur, particularly during dose escalation. Therefore, people should take care when driving or operating machinery if they feel dizzy.

The Australian product information also identifies conditions such as gallstones among reported adverse events. Accordingly, persistent or unusual abdominal symptoms should be discussed with a healthcare professional.

When Wegovy Symptoms Need Urgent Attention

Most reported reactions are not emergencies. Nevertheless, certain symptoms require prompt medical assessment.

For instance, acute pancreatitis is a serious potential reaction. Severe and persistent abdominal pain, particularly when it may extend towards the back, requires urgent medical attention.

Likewise, symptoms of a serious allergic reaction require urgent care. These can include widespread skin rash, difficulty breathing, wheezing, facial swelling, lip swelling or tongue swelling.

In addition, the Australian consumer information identifies bowel obstruction as a serious adverse reaction requiring medical attention. Therefore, severe or persistent digestive symptoms should not simply be ignored.

Updated Wegovy Safety Information

The TGA published a product-information safety update in June 2026 concerning semaglutide medicines, including Wegovy. The update added information about more serious gastrointestinal effects in people with gastroparesis, as well as non-arteritic anterior ischaemic optic neuropathy (NAION). It also added information concerning alopecia and cholecystitis.

Consequently, Australians should rely on the latest approved product information rather than older online descriptions of Wegovy safety.

Who Should Discuss Wegovy Safety?

Before using Wegovy, patients should tell their doctor about relevant medical conditions, medicines and previous allergic reactions. In particular, people with significant digestive problems should discuss their circumstances with a healthcare professional.

Furthermore, Wegovy should not be used during pregnancy according to the Australian product information. Breastfeeding is also listed as a situation where semaglutide should not be used.

If Wegovy is used with insulin or a sulfonylurea, the risk of low blood glucose may require additional attention. Therefore, patients should follow their prescriber’s advice about monitoring and treatment.

Managing Questions About Wegovy

If you experience Wegovy side effects, keep track of when symptoms begin and whether they change after a dose adjustment. This information can help your doctor or pharmacist assess the situation.

Additionally, avoid stopping prescribed treatment without discussing it with your healthcare professional. The Australian Consumer Medicine Information specifically advises patients not to stop Wegovy without medical advice.

For reliable information, Australians can check the current TGA product information and Consumer Medicine Information. The TGA lists Wegovy as a registered prescription medicine containing semaglutide.

Key Takeaways About Wegovy

Overall, Wegovy common side effects are mainly gastrointestinal and can include nausea, diarrhoea, constipation, vomiting and abdominal discomfort. However, serious reactions can also occur.

Therefore, anyone using semaglutide should understand the difference between expected digestive symptoms and warning signs that require medical attention. Persistent, severe or unusual symptoms should be discussed with a doctor or pharmacist.

Medical disclaimer: This article provides general educational information and is not a substitute for personalised medical advice. Wegovy is a prescription medicine. Always consult a qualified Australian healthcare professional before starting, changing or stopping treatment.